Zoetis Inc.

ZTS Healthcare Drug Manufacturers Specialty & Generic

Zoetis Inc.’s revenue for fiscal 2025 (year ended December 2025) was $9.5 billion, up 2.28% from fiscal 2024. In the quarter to June 2026, revenue was flat, EPS grew 2.48%, free cash flow grew 17.4% and total debt rose 37.5%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for ten; insiders bought in the last twelve months.

79.20 0.78 +0.99%
Market cap
$32.4B
P/E
13.0×
Fwd P/E
12.3×
Dividend yield
2.64%
F-score
7/9
Altman Z
5.73
Beneish M
−2.45
Dividend safety
88/100
Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
P/E ratio
32.48 40.78 29.00 42.15 48.11 56.75 32.56 38.77 29.73 20.87
Piotroski F-Score
7 8 6 6 7 9 4 9 8 7
P/S ratio
5.43 6.63 7.09 10.11 11.79 14.89 8.52 10.61 8.00 5.89
Altman Z-Score
4.46 5.17 4.79 6.26 6.80 9.79 6.26 8.59 7.51 5.73
Altman Z″-Score (non-manufacturers)
4.06 4.79 4.37 4.42 5.00 5.93 5.54 6.45 6.04 6.66
P/FCF ratio
45.26 30.34 27.40 46.67 46.46 66.60 51.89 55.92 32.20 24.44
Beneish M-Score
(2.39) (2.67) (2.51) (2.58) (2.76) (2.44) (2.38) (2.36) (2.61) (2.45)
P/Operating CF
92.89 57.83 70.76 108.73 109.60 170.48 92.92 101.06 81.77 62.48
Dividend Safety Score
— — — — — — — — — 88
P/B ratio
17.72 19.69 18.91 23.37 20.86 25.47 15.64 18.16 15.51 16.34
Price to Tangible BV
0.00 0.00 0.00 0.00 0.00 298.34 248.58 101.40 80.53 0.00
EV/Sales
6.20 7.41 7.91 10.83 12.33 15.29 9.06 11.14 8.49 6.73
EV/EBITDA
18.55 20.24 20.90 27.83 30.84 37.63 21.90 25.96 20.39 15.66
EV/Operating CF
42.51 29.20 25.74 37.77 38.71 53.73 38.27 40.45 26.61 21.95
EV/FCF
51.64 33.91 30.55 50.00 48.58 68.41 55.15 58.72 34.20 27.92
Quick Ratio
1.47 2.34 2.24 1.67 2.13 2.57 1.51 1.77 0.97 1.75
Current Ratio
3.03 3.85 3.60 2.63 3.05 3.86 2.37 3.36 1.75 3.03
Net Debt/EBITDA
2.29 1.75 2.16 1.85 1.35 1.00 1.29 1.23 1.19 1.65
Debt/Assets
58.41% 57.69% 59.87% 55.84% 52.90% 47.72% 52.96% 45.97% 46.15% 58.46%
Debt/Equity
2.98 2.77 2.95 2.38 1.91 1.46 1.80 1.32 1.38 2.71
Asset Turnover
0.63 0.65 0.60 0.56 0.53 0.57 0.56 0.59 0.65 0.64
Operating CF/Net income
0.87 1.56 1.25 1.20 1.30 1.09 0.90 1.00 1.19 1.09
Capex/Depreciation
(0.52) (0.77) (0.92) (1.07) (0.98) (1.06) (1.26) (1.49) (1.32) (1.28)
Interest Coverage
8.40 9.71 9.20 9.08 9.64 12.11 13.02 13.28 14.92 16.14
ROE
63.40% 52.60% 71.92% 61.31% 50.55% 48.98% 47.26% 49.90% 50.94% 65.99%
ROA
10.55% 10.64% 14.75% 13.44% 13.02% 14.81% 14.67% 16.05% 17.43% 18.00%
ROIC
14.65% 18.42% 15.23% 15.59% 16.93% 20.22% 19.02% 19.28% 20.94% 20.87%
Return on Tangible Assets
22.47% 18.96% 29.54% 30.73% 24.66% 26.96% 29.81% 30.61% 41.68% 32.54%
Average Days of Receivables
68.18 68.64 64.92 63.32 55.39 53.18 54.89 55.71 51.90 61.30
Research and Development Expense of Revenue
7.69% 7.20% 7.42% 7.30% 6.94% 6.53% 6.67% 7.19% 7.41% 7.37%
Selling, General and Administrative Expense of Revenue
27.91% 25.14% 25.48% 26.17% 25.86% 25.73% 24.86% 25.18% 25.04% 25.12%
Intangible Assets out of Total Assets
0.35 0.32 0.42 0.39 0.32 0.30 0.28 0.29 0.27 0.24
Share Based Compensation of Revenue
0.76% 0.83% 0.91% 1.07% 0.88% 0.75% 0.77% 0.70% 0.80% 0.88%
Graham Net Nets
(0.10) (0.07) (0.10) (0.06) (0.04) (0.02) (0.04) (0.03) (0.05) (0.09)
Graham Number
10.60 12.02 17.33 20.00 24.78 30.44 30.87 35.14 35.98 32.32
Earnings Yield
3.08% 2.45% 3.45% 2.37% 2.08% 1.76% 3.07% 2.58% 3.36% 4.79%
Free Cash Flow Yield
2.21% 3.30% 3.65% 2.14% 2.15% 1.50% 1.93% 1.79% 3.11% 4.09%
Revenue per Share
9.86 10.83 12.06 13.09 14.04 16.39 17.23 18.53 20.38 21.35
Operating CF per Share
1.44 2.75 3.71 3.75 4.47 4.67 4.08 5.10 6.50 6.55
Capex per Share
(0.25) (0.38) (0.58) (0.92) (0.91) (1.00) (1.25) (1.59) (1.44) (1.40)
Free Cash Flow per Share
1.18 2.37 3.12 2.84 3.56 3.66 2.83 3.52 5.06 5.15
Cash per Share
1.47 3.19 3.52 4.04 7.58 7.35 7.64 4.43 4.37 5.21
Shareholders Equity per Share
3.02 3.65 4.52 5.66 7.93 9.58 9.39 10.82 10.50 7.51
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
3.02 3.65 4.52 5.66 7.93 9.58 9.39 10.82 10.50 7.51
Free Cash Flow
587.00 1,159.00 1,508.00 1,356.00 1,694.00 1,738.00 1,327.00 1,621.00 2,298.00 2,283.00
Working Capital
2,273.00 3,123.00 3,176.00 2,942.00 4,441.00 5,133.00 4,339.00 4,454.00 2,574.00 4,533.00
Capital Expenditures
(126.00) (187.00) (282.00) (439.00) (432.00) (475.00) (585.00) (732.00) (655.00) (621.00)
Net Current Asset Value
(2,760.00) (2,583.00) (4,193.00) (4,089.00) (3,225.00) (2,426.00) (3,016.00) (2,952.00) (3,481.00) (5,368.00)
EV/EBIT
21.74 23.12 24.30 33.49 36.95 43.84 25.44 29.98 23.40 17.79
Capex to Sales
0.03 0.04 0.05 0.07 0.06 0.06 0.07 0.09 0.07 0.07
Price to Operating Income
21.63 23.06 24.45 35.14 39.43 46.53 25.92 30.88 23.62 16.61
Other line items
Depreciation/Fixed assets
0.17 0.17 0.19 0.21 0.20 0.19 0.17 0.15 0.15 0.13
Cash ROIC
8.77% 13.96% 14.59% 12.23% 11.62% 11.85% 8.35% 11.92% 17.24% 15.55%
Accounts Receivable Turnover
5.28 5.55 5.73 5.90 6.36 7.25 6.88 6.78 7.07 6.52
Accounts Payable Turnover
5.97 6.75 6.66 6.49 5.43 5.16 5.84 6.28 6.44 5.80
Inventory Turnover
1.12 1.21 1.36 1.42 1.35 1.30 1.15 1.04 1.12 1.13
Average Days of Payables
58.06 53.67 59.78 55.15 81.09 69.10 60.24 58.58 58.13 66.67
Days of Inventory on Hand
329.07 293.44 265.68 258.36 288.88 304.77 348.79 365.43 309.56 332.69
Average Receivables
925.00 955.50 1,017.00 1,061.00 1,049.50 1,073.00 1,174.00 1,259.50 1,310.00 1,453.00
Average Payables
279.00 263.00 287.00 307.00 379.00 446.50 420.50 408.00 422.00 460.00
Average Inventory
1,484.50 1,464.50 1,409.00 1,400.50 1,519.00 1,775.50 2,134.00 2,454.50 2,435.00 2,368.00
Average Assets
7,781.00 8,117.50 9,681.50 11,161.00 12,577.00 13,754.50 14,412.50 14,605.50 14,261.50 14,852.00
Average Common Equity
1,295.00 1,642.50 1,985.50 2,446.50 3,240.50 4,158.50 4,473.50 4,697.00 4,880.50 4,050.50

Fold the line items

Columns are period end dates